Given the significant investment made into developing Hadrian X, FBR owns valuable, tangible assets — including physical machines and a large intellectual property portfolio.
Instead of further diluting shareholders at depressed prices, FBR should seriously consider asset-backed lending.Key Points:
Leverage Existing Assets:
FBR owns Hadrian X machines ready for commercial deployment.
FBR holds approximately 140 granted patents covering automated bricklaying, construction robotics, and supporting technologies — protecting the technology globally.
These hard and soft assets could be used as collateral to unlock funding.
Immediate Cashflow: Asset-backed loans typically fund within weeks, faster and less damaging than issuing new equity.
Preserve Shareholder Value: No further dilution — shareholders retain their proportional ownership and upside potential.
Lower Cost of Capital: Even at higher interest rates, loans secured against assets are far cheaper than issuing new shares at today's low valuation.
Focus on Execution: Repayment can be linked to project revenues — incentivizing FBR to deploy Hadrian X aggressively.
With millions already invested into machinery and intellectual property, and a growing need for automation solutions globally, asset-backed financing deserves serious consideration before any further share issuance.
- Forums
- ASX - By Stock
- Asset-Backed Lending: A Smarter Alternative to Further Dilution
FBR
fbr ltd
Add to My Watchlist
25.0%
!
0.5¢

Given the significant investment made into developing Hadrian X,...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.5¢ |
Change
0.001(25.0%) |
Mkt cap ! $29.58M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.4¢ | $33.21K | 7.303M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
115 | 56622137 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 67222625 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
115 | 56622137 | 0.004 |
46 | 37914662 | 0.003 |
22 | 31419000 | 0.002 |
25 | 82028033 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 67222625 | 18 |
0.006 | 40876579 | 75 |
0.007 | 15845897 | 22 |
0.008 | 5352280 | 9 |
0.009 | 4393024 | 8 |
Last trade - 16.10pm 21/08/2025 (20 minute delay) ? |
Featured News
FBR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, MD & CEO
Michael Thurn
MD & CEO
SPONSORED BY The Market Online